Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: A pilot study

Pediatric Blood and Cancer

Volumn 61, Issue 8, 2014, Pages 1440-1444

  Friedman, Danielle Novetsky ^a   Lis, Eric ^a   Sklar, Charles A ^a,b   Oeffinger, Kevin C ^a   Reppucci, Marina ^a   Fleischut, Megan Harlan ^a   Francis, Jasmine H ^a   Marr, Brian ^a   Abramson, David H ^a,b   Dunkel, Ira J ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Pediatric oncology; Retinoblastoma; Screening; Survivors; Whole body MRI

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER SCREENING; CANCER STAGING; CANCER SURVIVOR; CHILD; CHONDROBLASTOMA; CLINICAL ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE SCANNER; OSTEOSARCOMA; PILOT STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RETINOBLASTOMA; SENSITIVITY AND SPECIFICITY; SPONDYLOLYSIS; SUBSEQUENT MALIGNANT NEOPLASM; WHOLE BODY MRI;

PEDIATRIC ONCOLOGY; RETINOBLASTOMA; SCREENING; SURVIVORS; WHOLE-BODY MRI;

CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS, SECOND PRIMARY; OSTEOSARCOMA; RETINOBLASTOMA; RETROSPECTIVE STUDIES;

EID: 84902009435     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24835     Document Type: Article

References (20)

1. Broaddus E, Topham A, Singh AD. Survival with retinoblastoma in the USA: 1975-2004. Br J Ophthalmol 2009; 93:24-27.
2. Kleinerman RA, Tucker MA, Abramson DH, et al. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst 2007; 99:24-31.
3. MacCarthy A, Bayne AM, Draper GJ, et al. Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004. Br J Ophthalmol 2009; 93:1159-1162.
4. Marees T, Moll AC, Imhof SM, et al. Risk of second malignancies in survivors of retinoblastoma: More than 40 years of follow-up. J Natl Cancer Inst 2008; 100:1771-1779.
5. Moll AC, Imhof SM, Bouter LM, et al. Second primary tumors in patients with retinoblastoma. A review of the literature. Ophthalmic Genet 1997; 18:27-34.
6. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 1993; 85:1121-1128.
7. Yu CL, Tucker MA, Abramson DH, et al. Cause-specific mortality in long-term survivors of retinoblastoma. J Natl Cancer Inst 2009; 101:581-591.
8. Wong FL, Boice JD, Jr., Abramson DH, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 1997; 278:1262-1267.
9. Lauenstein TC, Goehde SC, Herborn CU, et al. Whole-body MR imaging: Evaluation of patients for metastases. Radiology 2004; 233:139-148.
10. Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body imaging of the musculoskeletal system: The value of MR imaging. Skelet Radiol 2007; 36:1109-1119.
11. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012; 62:147-172.
12. Villani A, Tabori U, Schiffman J, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: A prospective observational study. Lancet Oncol 2011; 12:559-567.
13. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001; 86:5658-5671.
14. Field M, Shanley S, Kirk J. Inherited cancer susceptibility syndromes in paediatric practice. J Paediatr Child Health 2007; 43:219-229.
15. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: A systematic review. JAMA 2012; 307:2418-2429.
16. Abramson DH, Melson MR, Dunkel IJ, et al. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma. Ophthalmology 2001; 108:1868-1876.
17. Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: An extended follow-up. J Clin Oncol 2005; 23:2272-2279.
18. Rodjan F, Graaf P, Brisse HJ, et al. Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: Clinic and radiologic characteristics and survival outcomes. Eur J Cancer 2013; 49:1939-1947.
19. Kleinerman RA. Radiation-sensitive genetically susceptible pediatric sub-populations. Pediatr Radiol 2009; 39:S27-S31.
20. Gopie JP, Vasen HF, Tibben A. Surveillance for hereditary cancer: Does the benefit outweigh the psychological burden?-A systematic review. Crit Rev Oncol/Hematol 2012; 83:329-340.